Another throw-away IMO.
I'm not sure they know what they're doing right now. (Thought it desn't stop them paying themselves more money).
Seems from the report their previous expectations have come to diddly-squat, (so far) and they're scratching their heads wondering what to do next to generate some cash.
Hence, the recently introduced staff 'incentives' scheme - whatever that means.
Looks like it might mean any SGH client is going to be squeezed for more fees.
Sounds like fun to me.
- Forums
- ASX - By Stock
- SGH
- The Elephant in the room - SGH's future
The Elephant in the room - SGH's future, page-233
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online